Joint Stock Company Kaspi.kz ('Kaspi.kz”, 'we”) (Nasdaq:KSPI) today published its unaudited consolidated IFRS financial results for the quarter ended 31 March 2026 ('1Q 2026”).
BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) have become two of the most pressing healthcare challenges worldwide, driving rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results